T he inauguration of the National Registration and Accreditation Scheme (NRAS) in July 2012 marked a significant milestone in the history of Chinese medicine (CM) in Australia. Although it has been a recent achievement, it has been made possible because of the hard work and dedication of many individuals and organizations over the past years. 1 The positive impacts experienced throughout the legislative process have grown within economics, education, and culture. However, it is important to note that there are problems concerning CM education, standardization and scientization, and CM products themselves, which will impede further development of CM worldwide. To address these problems, in this paper, we put forward eight constructive suggestions from both government and pharmaceutical corporations' points of view, and firmly states that a convergence between CM and mainstream medicines will greatly benefit human healthcare in the foreseeable future.
Positive impacts on CM
Pertaining to public health Medicare has been the Commonwealth Government's universal health insurance scheme since 1984. In 1996 and 1997, the Australian Commonwealth Health Insurance Commission paid over USD 17.7 million in medicare rebates for 960 000 acupuncture treatments by registered medical practitioners. 2 However, to make up for the defects of limited public healthcare resources for such a large population, people are encouraged to have private health insurance. Since 1990, a majority of the Australian private health insurance corporations (e.g. Medibank Private Health Insurance) have also provided rebates for acupuncture performed by registered medical practitioners. These two facts clearly demonstrate the high popularity and recognition of acupuncture in Australia. Therefore, it is positive that with NRAS, more and more residents will be able to enjoy rebates for acupuncture and even Chinese Materia Medica (CMM) in the future.
Pertaining to economics CM has existed in Australia since the gold rush. Currently, there are approximately 5 000 CM clinics in Australia, providing treatment to patients of all ages. 3 Average fees for each acupuncture treatment is AUD 30. The average weekly cost of CMM is AUD 98 and a full course treatment can amount to around AUD 670. 4 Meanwhile, the increasing number of CM clinics and pharmacies indicates an enormous potential for the CM market.
It is reported that there are 600 to 800 kinds of CM products sold in the Australian market. 5 CM products, whose supply is regulated by Therapeutic Goods Administration (TGA) and Good Manufacturing Practice (GMP), fall into two categories: (1) Australian Listed (AUST L) medicines: generally lower-risk items, usually self-selected by consumers for treatment. To date, there are over 500 "AUST L" CMM products. (2) Australian Registered (AUST R) medicines: high-risk items whose efficacy must be demonstrated before they can be registered. Till date, there are no "AUST R" CM products in the Australian market. 6 In short, CM products development in the future calls for relentless endeavor towards "AUST R" CM products.
with universities, training schools offer more flexibility for students in choosing various courses based on their interests.
All in all, both CM formal education and vocational training are playing important roles in CM development in Australia and around the world.
Pertaining to culture CM evolves from a unique cultural atmosphere, which is an honest vehicle for CM development. Thus, it is pleasant to know that CM has already had so much support from the public as demonstrated by the increasing number of CM associations.
So far, there are 23 academic societies with respect to CM, most of which were established after 1985. 9 The top two societies include: 10 (1) the Australian Acupuncture and Chinese Medicine Association, resulting from the merger of the Australian Acupuncture Association and the Acupuncture Ethics Organization. It has more than 2 200 acupuncturists and Chinese medicine practitioners as members and was granted AUD 100 000 by the Australian federal government for better development of CM and the construction of a national unified registration system; (2) the Federation of Chinese Medicine and Acupuncture Societies of Australia, led by Prof. Tzi Chiang Lin, is a national CM organization that includes more than 700 members with a minimum of a CM bachelor degree or its equivalent.
Considering the tremendous hardship these societies would have encountered over the years, it is indeed thrilling to see them thrive.
Arguments against NRAS
Despite the positive impact of NRAS, there is concern regarding the possible negative impact it may have on the profession in the long term. These concerns include financial cost of registration, loss of diversity in practice, and decrease in creativity. Of these, financial cost has been most sharply criticized.
According to a latest report, only 13% of CM practitioners in Australia finished registration successfully with a qualified IELTS score of 7.0 or above and the rest were conditionally registered, 25% of which were restrained. 11 Conditional registration requires the practitioner to have a translator in service. Ironically, the initial fee for treatment is AUD 60−70, with discounts for the following visits; however, onside interpreting, according to the Australian Translating and Interpreting Service (TIS National), is AUD 163.35 for the first 90 minutes and AUD 54.01 for each 30 minutes thereon, and a full-day onside service charges AUD 44 for each 30 minutes. 9 Though the CM profession has been given a few years to catch up with the national standard of English language proficiency, the financial burden they are subjected to now will undoubtedly impede their development and even survival.
Problems regarding CM education
Low admission requirements CM education in China is universally run by the State. In the five-year full-time education program, it is mandatory for students to have at least 60 weeks for clinical internship. 12 All the entrance exams for the bachelor, master, and doctorate degrees are held annually by the Chinese government. However, in Australia, the bachelor degree for CM requires four-year full time study (five years in RMIT). For students who want to pursue a Master or PhD in CM, non-written exam is required.
Limited teaching resources CM education in Australia is job-oriented, and mainly focused on acupuncture and Chinese tuina. 13 Some schools like in US, do have CMM programs, but only for graduate students. 14 No Western medicine courses are provided for students due to medical scope restrictions for the CM practitioners in Australia, which is obviously different from that in China. What's more, the faculty strength differs enormously. Some are graduates from domestic CM universities; some may have had CM training lessons in China; and others possibly received relevant courses in Australia. 15 Numbered teaching hardware Till date, there are neither universities or hospitals in Australia that are solely devoted to CM; nor are there CM facilities within the Australian government run medical system. However, in China, there are 23 higher universities and more institutions providing CM education, apart from the independent CM schools in western medicine universities. 16 What is more, universities are equipped with independent labs, libraries, several affiliated hospitals and teaching hospitals, providing enough work guarantee for domestic students.
Comparing the software and hardware resources for teaching, it is evident that major gaps exist between domestic CM education and Australian regular CM education, let alone those irregular ones.
Problems regarding CM standardization
Till date, there are approximately 3 000 students travelling to China every year for CM study; the number of CM schools abroad has increased to hundreds. 17 Therefore, it is imperative to have an internationally accepted standard for global CM education.
In the latter half of the 20th century, CM textbooks were created for the first time in China. Some of the first training program textbooks became the precursors for some of the first English language textbooks available in Australia and the West. For example, Manfred Porkert's Theoretical 19 In November, the International Standard Chinese-English Basic Nomenclature of Chinese Medicine formulated by World Federation of Chinese Medicine Societies was published. Despite several contradictions in these two versions, they at least serve as prototypes for future CM standardization. Yet, two problems remain, namely, how can we possibly come up with a universally agreed version and can we be sure that it will be accepted and applied to CM schools worldwide?
Problems regarding CM scientization and modernization
For many years, Western medicine has conquered the world as a scientific medical practice, because it is based on physical objectivity. The supremacy of Western medicine today still relies essentially on the cultural dominance of a rationalist mentality, which considers physical objectivity as the unique parameter of truth.
It is because of this fundamental difference in methodology that CM is criticized as not-scientific and even labeled as supernatural in some cases. To fit CM into mainstream medicine, more researches are being performed with experimental methods, which involve two major lines: clinical trials using randomization, with double-blind placebo control, which require statistical analysis and metaanalysis and basic research that aims at proving or replacing classical theories by scientific explanations since 1951.
Obviously, most of the modernization of CM stems largely from a preference for modern Western medicine. Nevertheless, these evidences today are not convincing enough to make the Western medicine supporters accept CM.
Problems regarding CM products Safety
Contrary to the popular belief that CM products are all natural and therefore safe, there are many reports of severe toxicity and even death from consumption of certain toxic components. Thus, the safety in CMM is a major concern for CM practitioners, pharmacists, and other healthcare professionals, 20 CM products that may cause fatality are listed in Table 1 . 21 Although most of AUST L CM products are supposed to contain ingredients that have been evaluated by the TGA to be low risk and manufactured by licensed manufacturers in accordance with GMP, the specific chemical components in each CM product and possible contamination and adulteration remain unclear. For example, analgesics and non-steroidal anti-inflammatory drugs are the most commonly used OTC drugs. There are a number of reports of adulteration in CMM by analgesics. Various classes of Western medicines commonly found in CMM are listed in Table 2 . 21 CM products are preferred by the public due to its effectiveness and affordability and the general perception that they are safe and harmless. Thus, there is a need for more structured and controlled regulation of CM products used in Australia. It is also highly recommended that toxicological evidence of CM products must be reviewed for patients' safety and the practitioners' right to prescribe the most efficacious, yet safe Chinese herbs and products. 22
Quality control
Apart from toxic and dangerous CM products and their possible contamination when mixed with Western drugs, the quality control of CM products is worth mentioning. CM products from China are contaminated with heavy metals, pesticide residues, or even mycotoxins. For instance, lead poisoning is the most commonly reported problem after consumption of contaminated CM products, apart from arsenic, mercury, or cadmium poisoning.
There are two major routes through which heavy metals and pesticides get incorporated into CM products: unintended inclusion during plant growth or processing of the source material and intentional addition during preparation of the final product because heavy metals are part of the ancient formulas. 21 CM practitioners believe that the metal ingredients are "detoxified" prior to inclusion in the treatment, but this point has not been proved by scientific research. Accordingly, all such metals and stones are forbidden in medicine in Australia.
Intellectual property
Over 210 CM formulas have been developed into Japanese drugs over the years, covering 80% of the global market for complementary and alternative medicine. 23 Tsumura & Co, the largest manufacturer and dealer among over 700 Chinese formulas manufacturing enterprises in Japan, has developed Jiuxindan on the basis of Liushenwan and has achieved an annual sale of USD 100 000 000. This almost equals the annual export volume of all CM products in China. 24 Therefore, it is fair to say that CM intellectual property is under great threat.
The 56th World Health Assembly in May 2003 passed a bill, which states that traditional medicines are the treasures of their places of origin, and urges the member countries to carry out appropriate protective measures. Detailed measures formulated by World Intellectual Property Organization cover the intellectual property protection of formulas, medicinal books and national-wide special protective systems.
With severe insufficiency in public awareness of CM intellectual property and the global trend for its legislation, this problem has been finally raised as a public concern.
Measures suggested
The past years have witnessed the Chinese government's efforts in promoting CM development in an all-round manner. However, with economic globalization and increasing foreign enterprise involvement, the external environment for CM development has become more and more sophisticated, thus more indemnificatory measures from the government would be greatly appreciated for better CM development worldwide.
Establishment of a specific department for CM export to maintain standards CM products export obstacles have existed for years, the reasons for which can be classified into two: intentional trade barriers set up by foreign countries and objective quality problems in CM products. 20 Therefore, it is of great importance for the government to form a dedicated department to deal with the two main issues. In this way, CM products export can work as an important condition for trade negotiation among governments. And with quality supervision by this special department, opportunistic manufacturers can be largely avoided.
Emphasize CM transmission through cultural exchange by building a worldwide CM network
The propagation of CM to the future world should not just rely on its efficacy in clinical medical care, but also in its unique wisdom concerning a way of life and health-related culture. Hence, it is important to expand CM cultural transmission, thus building a sound academic atmosphere for CM. We also suggest that the government should organize experts to translate and publish CM books and conduct CM exposition and festivals at home and abroad.
In addition, we should also get familiar with foreign cultures so that we can generate ways to make it easier for foreigners to accept the CM culture. 12
Transform domestic CM education system and generate human resource
Talented personnel are keys to the development of each specialty, and they are the foundation for the internationalization of CM. 25 Consequently, it is better for domestic CM education to transform from the examoriented pattern to quality-oriented one that will cultivate innovative talent. For this goal, it is necessary to improve faculty strength and optimize course arrangement to encourage creative and multi-talented personnel. These talents will not only benefit the modernization of CM at home, but also be targeted towards outputting projects, providing overseas students opportunities to experience the surprising efficacy of CM, and to comprehend what makes an authentic CM practitioner.
Boost international cooperation for CM education
Overseas CM education collaborations have always been stuck at the university level. For instance, Nanjing University of Chinese Medicine has established collaborative relationships with schools across 90 countries; still, there are only two government programs conducted via the Chinese and Italian governments. 26 Thus, it is crucial to elevate CM education collaboration levels, sending positive messages to the world. Meanwhile, the Chinese government should design preferential measures to attract more foreign students to study CM in China, which will initiate a new phase of securing international talents.
Establish CM intellectual property protection
Realizing the intellectual property laws now available fail to effectively protect the CM intellectual property, specific rules for CM protection are strongly expected. To achieve this objective, the following steps are needed; 27 set up a CM database to provide reference for CM intellectual property protection, such as catalogues for CM classical formulas and CMM, scope for TCM theories and clinical techniques for diagnosis and treatment, and project the clinical experience of national famous CM masters, and even set up trademarks for CM, such as Taiji. 28
Perspective of enterprises
With government supports should be the first step of a solid foundation, the efforts of CM products manufacturers are also critical to the big blueprint. The measures include as follows.
Establish business alliance to formulate industry standards The construction of a business alliance that will be in charge of setting the industry standards, direct supervision on quality control and problems coordination regarding price, profit distribution, and even penalty in CM products export should come first. 29 It is sincerely hoped that this organization can decrease vicious competition in this trade, and strengthen the overall competitive power of CM products worldwide so as to create a good international image.
Strengthen inter-enterprise cooperation to promote modernization Domestic manufacturing corporations can combine their strengths and work together on new drugs and state-ofart techniques. In this way, they can not only improve their competitive power, but also avoid cannibalism. If the domestic enterprise is strong enough, they can even cooperate with foreign pharmaceutical corporations, which will not only favor the international integration of domestic CM product industry, but also reduce possible international trade barriers
Adjust CM products structure and build up brand culture It is true that every giant pharmaceutical company has its own knock-out products, such as Nexavar and Adalat for Bayer, Atorvastatin and Norvasc for Pfizer. However, in the brand construction or knock-out products of CMM pharmaceutical corporations, we only have Tongrentang. Thus, the domestic CMM manufacturing companies should also adjust their product structure and set up their own brand culture gradually, maybe by collaboration, which will have a great impact on development in the long run.
Summary and further perspective
CM is based on the accumulation of experience and knowledge gathered over the centuries and the dedicated work of generations. It is heartening to see CM in Australia has already accomplished so much with respect to economics, education and culture. Still, we need to admit that due to problems in CM itself, NRAS is probably the one and only advanced policy that has truly accelerated CM development. As a consequence, CM's impact at a global scale is still limited, and its effects on mainstream medicine worldwide are minor, also attributed to the above average language requirement.
Still, we believe that at a time when the understanding of disease has become more sophisticated and when concepts of health are changing, we should not focus on reducing systems of healing into a unique pattern, but on enriching them. The best approach in developing future CM will be to integrate mainstream medicine with CM. To make this plan come true, joint efforts among different governments and enterprises across international borders should be strongly encouraged to ensure the safety and efficacy of CM. Above all, the spirit of cooperation with other medical branches can be and will be one of the real modern aspects of CM in the foreseeable future.
